Radiopharmaceutical Safety: Making It Easy.

The article focuses on the expanding use of therapeutic radiopharmaceuticals—agents combining pharmaceutical and radioactive properties—in cancer treatment and the associated safety challenges across healthcare settings. It highlights the importance of standardized safety protocols, interprofessional education, and clear communication to manage radiation exposure risks for patients and healthcare workers, especially as patients may receive treatment in one department and present in others shortly afterward. The article details mechanisms of action, common agents such as lutetium Lu 177 vipivotide tetraxetan and radium Ra 223 dichloride, and emphasizes nursing roles in patient education, safety advocacy, and interdepartmental coordination. It also describes a systemwide educational initiative at Johns Hopkins Health System to prepare clinical and nonclinical staff for safe radiopharmaceutical care. The article concludes that nurses are essential to implementing safe, effective radiopharmaceutical therapies through leadership in education, policy development, and collaborative practice.